跳至主要内容
临床试验/CTRI/2025/01/079217
CTRI/2025/01/079217尚未招募不适用

To evaluate the in vivo efficacy and safety of a skin care regime in terms of reduction in acne postinflammatory hyperpigmentation, improvement in skin even tone, skin brightness, hydration, Skin elasticity and skin gloss on healthy male subjects

Anveya Living Private Limited - Haryana1 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2025年2月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
72
试验地点
1
主要终点
Reduction in hyper-pigmentation (Acne PIH), improvement in skin even tone, skin brightness, hydration, Skin elasticity and skin gloss

研究概览

简要总结

OBJECTIVE:To evaluate the in-vivo efficacy and safety of a skin care regime in terms of reduction in hyper-pigmentation (Acne PIH), improvement in skin even tone, skin brightness, hydration, Skin elasticity and skin gloss on healthy male subjects

The evaluation is performed using: Subject Self Evaluation, Dermatological Evaluation Safety, Mexametry, Chromametry, Corneometry, Glossymeter, Cutometry

POPULATION: 72 (36 for test regime and 36 for placebo regime) male subjects will be selected for the study.

The subjects selected for this study are healthy males, aged between 18 and 40 years old,

STUDY DURATION: 28 days following the first application of the test product.

研究设计

研究类型
Interventional
分配方式
Na
盲法
Participant Blinded

入排标准

年龄范围
18.00 Year(s) 至 40.00 Year(s)(—)
性别
Male

入选标准

  • Indian male subjects.
  • Healthy subjects.
  • Skin is healthy on the studied anatomic unit 4)Having normal skin type with visible Acne PIH.

排除标准

  • Having refused to give his assent by not signing the consent form.
  • Taking part in another study liable to interfere with this study.
  • Being insulin-dependent diabetic or non-insulin-dependent diabetic with a recent therapy (less than 6 months)
  • Having progressive asthma.
  • Being epileptic.
  • Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months)
  • Having cutaneous hypersensitivity
  • Having a diagnosed or highly probable allergy to one or several compounds of cosmetic products.
  • Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol)
  • Having consumed caffeine-based products (coffee, cola, tea …), alcohol, highly spiced foods and/or smoked in the two hours preceding the measurements.
  • Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.
  • Having changed her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit
  • Having applied a cosmetic product (included make-up) or skin care product on the studied areas the day of the study (only face cleaned with water is accepted).

结局指标

主要结局

Reduction in hyper-pigmentation (Acne PIH), improvement in skin even tone, skin brightness, hydration, Skin elasticity and skin gloss

时间窗: Baseline, Day 7, Day 14, Day 28

次要结局

未报告次要终点

研究者

发起方
Anveya Living Private Limited - Haryana
申办方类型
Other [Non-government company ]
责任方
Principal Investigator
主要研究者

Dr Pooja Yadav

MASCOT-SPINCONTROL India Pvt. Ltd.

研究点 (1)

Loading locations...

相似试验

Study to check the safety and effectiveness of... | 临床试验